We are deploying our toolset for city use as public health infrastructure to better control the spread of the disease and connect local residents in major hotspots to public health officials, clinicians, epidemiologists and therapists. We will also use our matching platform to match local residents to testing facilities and treatment services. The infrastructure collects local data, self-reported health data, symptoms and co-morbidities to assess local residents risk level and rapidly triage at local levels.

Resilience - we're improving the broader infrastructure for responding to pandemic outbreaks.

I have a market-ready product/service. I could sell it to customers

My executive team has 60 years' combined experience in exiting life sciences companies including health tech, genomics, and embryology service companies. We have more than six exits and six acquisitions among us. We've successfully built global networks of professionals and global distribution channels. We have also established research collaborations with major universities and notable scientists across the world. We are aligned with multiple diagnostic providers for antibody testing nationwide. Our health tech toolset is utilized within 50% of the IVF market and easily translates into local public health infrastructure for major cities in the US. With legislative relationships in multiple states, access to a handful of city mayors and rich history and reputation in various areas of research, ability to engage board-certified medical professionals and motivate them to answer free questions, we believe we can implement a solution within a few short weeks.

United States but we have medical providers and experts in our network from the UK, Spain, Singapore, China, Mexico, Argentina, Canada, and Brazil.

Yes